Halle C. F. Moore
0000-0002-7472-9350
Publication & Citation Trends
Publications
0 total
Abstract RF1-04: Long-Term Follow-up and updated analysis from S0221, Comparing Alternative Dose-Schedules of Adjuvant Anthracycline/Taxane Therapy in High-Risk Early Breast Cancer
Cited by 0
Semantic Scholar
Open-label, phase II, multicenter study of lasofoxifene plus abemaciclib for treating women with metastatic ER+/HER2- breast cancer and an ESR1 mutation after disease progression on prior therapies: ELAINE 2. OA
Cited by 31
Semantic Scholar
Final Analysis of the Prevention of Early Menopause Study (POEMS)/SWOG Intergroup S0230. OA
Cited by 142
Semantic Scholar
Supplement use during an intergroup clinical trial for breast cancer (S0221) OA
Cited by 36
Semantic Scholar
Adjuvant therapy of colon cancer.
Cited by 0
Semantic Scholar
Research Topics
Cancer Risks and Factors
(42)
Cancer Treatment and Pharmacology
(39)
Breast Cancer Treatment Studies
(38)
Cancer survivorship and care
(29)
Advanced Breast Cancer Therapies
(29)
Affiliations
University of Southern California
Fox Chase Cancer Center
Loyola University Medical Center
Cleveland Clinic
Mayo Clinic